Metabolic medicines continue to be one of the hottest areas for drug research, so it should come as no surprise that deal flow for obesity and diabetes drugs was a particular highlight of biopharma ...

Health tech may be getting a new heavyweight — though the deal is still in its early stages. Last month, reports emerged that Matt Holt, former managing director and president of private equity at New ...

For the past couple of years, clinicians have been singing the praises of generative AI-powered clinical documentation tools, saying that these models give them hours back into their day. Industry ...

As lawmakers eye tougher oversight of pharmacy benefit managers, PBMs seem to be taking their own steps to rein in practices that have invited scrutiny. However, experts remain skeptical and say it ...

Look at recent big pharma asset acquisitions and new biotech company launches, and you might spot a common theme: The drugs at the heart of these deals were originally developed in China. The ...

Auxira Health, a virtual cardiology company, has raised $7.8 million in seed funding, which will help expand its footprint, the startup announced on Monday. Columbia, Maryland-based Auxira Health was ...

Leaders at Mount Sinai Health System in New York think Microsoft is the winner of the ambient scribing world — for now. The health system began rolling out Microsoft’s ambient listening technology, ...

Pearl's $110 million raise includes a $50 million equity investment led by Andreessen Horowitz with participation from Viking ...

The Improving Seniors’ Timely Access to Care Act passed out of the House Ways and Means Committee unanimously on Wednesday, a move that many healthcare advocates are applauding. Reps. Ami Bera ...

There are no FDA-approved treatments for recurrent chronic cough, and a GSK drug from a $2 billion acquisition just lost its chance to become the first one. The drug, camlipixant, was developed ...

Nearly 200 healthcare and patient advocacy organizations endorsed the bipartisan Clinical Trial Modernization Act, which seeks to reduce financial barriers and expand access to clinical trials for ...